Meshy Achieves $100M ARR After Raising $400M in Series B Funding
Meshy has surpassed $100 million in annual recurring revenue and secured $400M in a Series B round at a $1.5 billion valuation.
$400M1h ago
Read story
SaveMeshy
Daily stories about who raised, what they build, and where they hire.
Meshy has surpassed $100 million in annual recurring revenue and secured $400M in a Series B round at a $1.5 billion valuation.
TriGemX Bio has raised $94M in funding led by The Column Group, TCGX, and Viking Global Investors to advance elismetrep, a novel migraine treatment.
Toronto's Polygrade raises $6.3M to enhance its AI-driven claims software for warranty providers, aiming to streamline operations.
Tessolve Semiconductor has raised $75M led by Vector Line Capital, aiming to bolster growth and strategic acquisitions.
Healthleap has raised $30M in Series A funding led by Hummingbird Ventures to expand its AI platform that identifies undiagnosed conditions in hospitalized patients.